Receive a weekly summary and discussion of the top papers of the week by leading researchers in the field.

In Journal of Alzheimer's disease : JAD

BACKGROUND : Alzheimer's disease (AD) is a neurodegenerative disorder with homogenous disease patterns. Neuropathological changes precede symptoms by up to two decades making neuroimaging biomarkers a prime candidate for early diagnosis, prognosis, and patient stratification.

OBJECTIVE : The goal of the study was to discern intermediate AD stages and their precursors based on neuroanatomical features for stratifying patients on their progression through different stages.

METHODS : Data include grey matter features from 14 brain regions extracted from longitudinal structural MRI and cognitive data obtained from 1,017 healthy controls and AD patients of ADNI. AD progression was modeled with a Hidden Markov Model, whose hidden states signify disease stages derived from the neuroanatomical data. To tie the progression in brain atrophy to a behavioral marker, we analyzed the ADAS-cog sub-scores in the stages.

RESULTS : The optimal model consists of eight states with differentiable neuroanatomical features, forming two routes crossing once at a very early point and merging at the final state. The cortical route is characterized by early and sustained atrophy in cortical regions. The limbic route is characterized by early decrease in limbic regions. Cognitive differences between the two routes are most noticeable in the memory domain with subjects from the limbic route experiencing stronger memory impairments.

CONCLUSION : Our findings corroborate that more than one pattern of grey matter deterioration with several discernable stages can be identified in the progression of AD. These neuroanatomical subtypes are behaviorally meaningful and provide a door into early diagnosis of AD and prognosis of the disease's progression.

Hollenbenders Yasmin, Pobiruchin Monika, Reichenbach Alexandra

2023-Mar-06

Alzheimer’s Disease Neuroimaging Initiative, Alzheimer’s disease, brain atrophy, clustering, hidden Markov model, longitudinal data, magnetic resonance imaging, patient stratification, subtype